Registration Strip Icon for monitor Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.

Krystal Biotech (KRYS)

Krystal Biotech Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:KRYS
DateTimeSourceHeadlineSymbolCompany
07/06/202423:09PR Newswire (US)KKR, CrowdStrike Holdings and GoDaddy Set to Join S&P 500; Others to Join S&P MidCap 400 and S&P SmallCap 600NASDAQ:KRYSKrystal Biotech Inc
05/06/202412:00GlobeNewswire Inc.Krystal Biotech to Present at Goldman Sachs 45th Annual Global Healthcare ConferenceNASDAQ:KRYSKrystal Biotech Inc
21/05/202421:38Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:KRYSKrystal Biotech Inc
15/05/202412:00GlobeNewswire Inc.Krystal Biotech to Present at the American Thoracic Society 2024 International ConferenceNASDAQ:KRYSKrystal Biotech Inc
08/05/202412:00GlobeNewswire Inc.Krystal Biotech to Present at BofA Securities 2024 Health Care ConferenceNASDAQ:KRYSKrystal Biotech Inc
06/05/202413:17Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:KRYSKrystal Biotech Inc
06/05/202413:09IH Market NewsIndex Futures Point to Strong Monday Opening, Building on Last Week’s Gains; Oil Prices RiseNASDAQ:KRYSKrystal Biotech Inc
06/05/202413:04Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:KRYSKrystal Biotech Inc
06/05/202413:00GlobeNewswire Inc.Krystal Biotech Announces First Quarter 2024 Financial Results and Provides Business UpdatesNASDAQ:KRYSKrystal Biotech Inc
02/05/202412:00GlobeNewswire Inc.Krystal Biotech to Present at the Association for Research in Vision and Ophthalmology 2024 Annual MeetingNASDAQ:KRYSKrystal Biotech Inc
26/04/202412:00GlobeNewswire Inc.Krystal Biotech to Report First Quarter 2024 Financial Results on May 6, 2024NASDAQ:KRYSKrystal Biotech Inc
22/04/202412:00GlobeNewswire Inc.Krystal Biotech Announces First Patient Dosed in Phase 1 Clinical Trial of Inhaled KB707 for the Treatment of Locally Advanced or Metastatic Solid Tumors of the LungNASDAQ:KRYSKrystal Biotech Inc
04/04/202412:00GlobeNewswire Inc.Krystal Biotech to Present at the American Association for Cancer Research 2024 Annual MeetingNASDAQ:KRYSKrystal Biotech Inc
02/03/202401:20Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:KRYSKrystal Biotech Inc
02/03/202401:16Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:KRYSKrystal Biotech Inc
29/02/202402:33Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:KRYSKrystal Biotech Inc
28/02/202412:00GlobeNewswire Inc.Krystal Biotech to Present at TD Cowen 44th Annual Health Care ConferenceNASDAQ:KRYSKrystal Biotech Inc
26/02/202418:35Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:KRYSKrystal Biotech Inc
26/02/202413:04Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:KRYSKrystal Biotech Inc
26/02/202413:00GlobeNewswire Inc.Krystal Biotech Announces Fourth Quarter and Full Year 2023 Financial Results and Provides Business UpdatesNASDAQ:KRYSKrystal Biotech Inc
26/02/202412:59Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:KRYSKrystal Biotech Inc
26/02/202412:49Edgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]NASDAQ:KRYSKrystal Biotech Inc
26/02/202410:57IH Market NewsU.S. Index Futures Dip Amid Inflation Data Anticipation, Oil and Iron Ore Prices RetreatNASDAQ:KRYSKrystal Biotech Inc
20/02/202412:00GlobeNewswire Inc.Krystal Biotech to Report Fourth Quarter and Full Year 2023 Financial Results on February 26, 2024NASDAQ:KRYSKrystal Biotech Inc
13/02/202412:00GlobeNewswire Inc.Krystal Biotech Receives FDA Fast Track Designation for Inhaled Oncology Candidate KB707 to Treat Solid Tumors of the LungNASDAQ:KRYSKrystal Biotech Inc
08/02/202412:00GlobeNewswire Inc.Krystal Biotech Announces Publication in the New England Journal of Medicine on the Application of B-VEC to Treat Ocular Complications in Patient with Dystrophic Epidermolysis BullosaNASDAQ:KRYSKrystal Biotech Inc
01/02/202412:00GlobeNewswire Inc.Krystal Biotech to Present at Guggenheim 6th Annual Biotechnology ConferenceNASDAQ:KRYSKrystal Biotech Inc
24/01/202422:44Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:KRYSKrystal Biotech Inc
22/01/202416:43Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:KRYSKrystal Biotech Inc
04/01/202412:00GlobeNewswire Inc.Krystal Biotech Receives Permanent J-code (J3401) for VYJUVEK®NASDAQ:KRYSKrystal Biotech Inc
 Showing the most relevant articles for your search:NASDAQ:KRYS